Table 1. Subject Characteristics Subject... | American Society of Hematology

Table 1.

Subject Characteristics

Subject^*	Age (yr)/Sex	CD4⁺ T-Cell Count (cells/μL)^†	Antiretroviral Therapy
CoH-1	47/F	289	AZT
CoH-2	32/M	451	AZT/ddI
CoH-3	48/F	691	None

Subject^*	Age (yr)/Sex	CD4⁺ T-Cell Count (cells/μL)^†	Antiretroviral Therapy
CoH-1	47/F	289	AZT
CoH-2	32/M	451	AZT/ddI
CoH-3	48/F	691	None

Abbreviations: AZT, azidothymidine; ddI, didanosine.

Subjects CoH-1, CoH-2, and CoH-3 are subjects UPN-04, UPN-05, and UPN-07, respectively, in the study by Zaia et al (manuscript in preparation).

The CD4⁺ T-cell count was determined at a study begun before G-CSF administration.